The Online Books Page

Drugs -- United States -- Costs

See also what's at your library, or elsewhere.

• Drugs -- United States
• Costs

• Immunosuppressive agents -- United States -- Costs

• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu

• Outpatient Immunosuppressive Drugs Under Medicare (OTA-H-452; 1991), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

Items below (if any) are from related and broader terms.

• Patent-Term Extension and the Pharmaceutical Industry (OTA-CIT-143; 1981), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Postmarketing Surveillance of Prescription Drugs (1982), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• Cancer Patient Access to Unapproved Treatments: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, Second Session, February 29, 1996 (Washington: GPO, 1996), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)

• Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)

• The Border War on Drugs (1987), by United States Congress Office of Technology Assessment (PDF files at Princeton)
• The War on Marijuana in Black and White (with correction made Sep 2013; New York: American Civil Liberties Union, 2013), by Ezekiel Edwards, Will Bunting, and Lynda Garcia (PDF with commentary at aclu.org)
• Castro and the Narcotics Connection: Special Report (original and government-derived content only; copyrighted media reports omitted; 1983), by Cuban American National Foundation (U.S.) (multiple formats at archive.org)
• Caught in the Net: The Impact of Drug Policies on Women and Families (New York: ACLU; Brennan Center for Justice; Break the Chains, ca. 2005), by Lenora M. Lapidus, Namita Luthra, Anjuli Verma, Deborah Small, Patricia E. Allard, and Kirsten D. Levingston, contrib. by Andrea J. Ritchie (PDF with commentary at brennancenter.org)
• Sea Carrier Security Manual (Washington: Dept. of the Treasury, U.S. Customs Service, Carrier Initiative Program, 1989), by U.S. Customs Service Carrier Initative Program (page images at HathiTrust)
• Agency of Fear: Opiates and Political Power in America, by Edward Jay Epstein (illustrated HTML at edwardjayepstein.com)
• Alternative Coca Reduction Strategies in the Andean Region (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Agency of Fear: Opiates and Political Power in America, by Edward Jay Epstein (illustrated HTML at edwardjayepstein.com)

• Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
• Federal and Private Roles in the Development and Provision of Alglucerase Therapy for Gaucher Disease (Washington: Office of Technology Assessment, 1992), by Alan M. Garber, Ann E. Clarke, Dana P. Goldman, and Michael E. Gluck (PDF files at Princeton)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Drug Labeling in Developing Countries (1993), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• The Drug Hang-Up: America's Fifty-Year Folly, by Rufus King (HTML at druglibrary.org)

• Between Politics and Reason: The Drug Legalization Debate, by Erich Goode (HTML at druglibrary.org)

• An Offer You Can't Refuse: How US Federal Prosecutors Force Drug Defendants to Plead Guilty (New York et al.: Human Rights Watch, 2013), by Jamie Fellner (HTML and PDF with commentary at hrw.org)

• The Toadstool Millionaires: A Social History of Patent Medicines in America Before Federal Regulation, by James Harvey Young (HTML at quackwatch.com)

• Nursing and the Privilege of Prescription, 1893-2000 (Columbus, OH: Ohio State University Press, c2007), by Arlene Wynbeek Keeling (PDF at Ohio State)

• Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
• Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies (Washington: AEI Press, 1999), by Patricia Munch Danzon (PDF with commentary at AEI)

• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Prescription for the People: An Activist's Guide to Making Medicine Affordable for All (Ithaca, NY and London: ILR Press, c2017), by Fran Quigley (PDF and Epub with commentary at Cornell Open)
• Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies (Washington: AEI Press, 1999), by Patricia Munch Danzon (PDF with commentary at AEI)

• Pharmaceutical R&D: Costs, Risks, and Rewards (OTA-H-522; 1993), by United States Congress Office of Technology Assessment (page images at HathiTrust)

• Developing New Contraceptives: Obstacles and Opportunities (1990), ed. by Luigi Mastroianni, Peter J. Donaldson, and Thomas T. Kane (page images with commentary at NAP)

• Cost Effectiveness of Carbon Monoxide Control Strategies (Chicago: Illinois Institute for Environmental Quality, 1973), by Jay E. Norco (page images at HathiTrust; US access only)

• Remotely Sensed Data From Space: Distribution, Pricing, and Applications (Washington, DC: U.S. Congress, Office of Technology Assessment, International Security and Commerce Program, 1992), by United States Congress Office of Technology Assessment (PDF at unt.edu)

• Investing in Our Children: What We Know and Don't Know About the Costs and Benefits of Early Childhood Interventions, by Lynn A. Karoly, Peter W. Greenwood, Susan S. Everingham, Jill Houbeé, M. Rebecca Kilburn, C. Peter Rydell, Matthew Sanders, and James Chiesa (PDF files at rand.org)

• The Economic Costs and Implications of High-Technology Hardware Theft (c1999), by James N. Dertouzos, Eric V. Larson, and Patricia A. Ebener (PDF files at rand.org)

• The Economic Costs and Implications of High-Technology Hardware Theft (c1999), by James N. Dertouzos, Eric V. Larson, and Patricia A. Ebener (PDF files at rand.org)

• The Impact of AIDS on the Kaiser Permanente Medical Care Program (Northern California Region) (Washington: Office of Technology Assessment, 1988), by Kaiser-Permanente Medical Care Program, Northern California Region
  • page images at HathiTrust
  • PDF files at Princeton

• International Comparisons of Administrative Costs in Health Care (Washington: GPO, 1994), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• International Comparisons of Administrative Costs in Health Care (Washington: GPO, 1994), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• International Comparisons of Administrative Costs in Health Care (Washington: GPO, 1994), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files at Princeton

• The Economic Costs and Implications of High-Technology Hardware Theft (c1999), by James N. Dertouzos, Eric V. Larson, and Patricia A. Ebener (PDF files at rand.org)

• Local Fiscal Effects of Illegal Immigration: Report of a Workshop (1996), ed. by Barry Edmonston and Ronald Demos Lee (page images with commentary at NAP)

• The Political Economy of Workplace Injury in Canada (c2010), by Bob Barnetson (PDF with commentary at AU Press)

• Effects of Federal Policies on Extracorporeal Shock Wave Lithotripsy (1986), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Affordable Spacecraft: Design and Launch Alternatives (1990), by United States Congress Office of Technology Assessment (PDF files at Princeton)

• Debts, Job Choices, and Financial Burden: Educational Debts at Nine American Law Schools (Washington: Association of American Law Schools, 1991), by David L. Chambers (PDF with commentary at Michigan)

• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu

• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu

• Recombinant Erythropoietin: Payment Options for Medicare (OTA-H-451; 1990), by United States Congress Office of Technology Assessment (page images at HathiTrust)
• Payment for Physician Services: Strategies for Medicare (OTA-H-294; 1986), by United States Congress Office of Technology Assessment (PDF files at Princeton)
• Prices, Markets, and the Pharmaceutical Revolution (Washington: AEI Press, 2000), by John E. Calfee (PDF at AEI)
• Medical Technology and Costs of the Medicare Program (OTA-H-227; 1984), by United States Congress Office of Technology Assessment
  • page images at HathiTrust
  • PDF files with commentary at Princeton
  • PDF at unt.edu

More items available under broader and related terms at left.